Back to Search Start Over

Challenges in the management of Turner syndrome with Y chromosome material: a case report of prophylactic gonadectomy revealing dysgerminoma.

Authors :
Tanioka A
Matsukawa Y
Sakamoto K
Matsuda Y
Moritani S
Maruo Y
Source :
International cancer conference journal [Int Cancer Conf J] 2024 Jan 12; Vol. 13 (2), pp. 108-110. Date of Electronic Publication: 2024 Jan 12 (Print Publication: 2024).
Publication Year :
2024

Abstract

Turner syndrome (TS) patients with Y chromosome material face an increased risk of gonadal germ cell tumors (GCTs). This case report discusses the challenges in decision-making regarding prophylactic gonadectomy, considering the risk of malignancy and the desire to preserve fertility. We report a case of a 12-year-old female with mosaic TS and Y chromosome material who initially presented with short stature and obesity. Karyotype analysis showed a mixed cell line (45X and 46XY). Counseling about the increased risk of developing GCT and preservation of gonadal function was provided, and we decided to delay gonadectomy until the age of 12. Prophylactic bilateral gonadectomy revealed dysgerminoma associated with GB at the age of 12. Fortunately, the patient was asymptomatic, with no additional therapy required due to the early stage of the disease. The case highlights the dilemma in managing TS patients with Y chromosome material, where the risk of GCT varies depending on the type of difference in sex development and gonadal function. The decision to delay gonadectomy reflects the emphasis on preservation of ovarian, although it poses a risk of malignancy. This case underscores the importance of individualized care in TS patients with Y chromosome material, balancing the risk of malignancy against preservation of ovarian. It emphasizes the need for timely and personalized decision-making in prophylactic gonadectomy.<br />Competing Interests: Conflict of interestThe authors declare no competing financial interests.<br /> (© The Author(s) under exclusive licence to The Japan Society of Clinical Oncology 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)

Details

Language :
English
ISSN :
2192-3183
Volume :
13
Issue :
2
Database :
MEDLINE
Journal :
International cancer conference journal
Publication Type :
Academic Journal
Accession number :
38524661
Full Text :
https://doi.org/10.1007/s13691-023-00645-3